News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VaxInnate Corporation Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine to Biological E. Limited; Vaccine Could Become Available for Use in India This Year


1/12/2010 10:27:52 AM

CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES